drugset / Trial / NCT00587444

Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass

NCT00587444

Phase 3 Completed 270 enrolled Mayo Clinic Medtronic · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Study has been completed and is in the data analysis and manuscript writing phase of the project.

Timeline

Start
2001-06
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 300 iu/kg
Subject Heparin Other / unclassified 450 iu/kg

Indications

No indication recorded.